NCT02612311 · Interventional trial
Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia
Overall registry status Terminated
Phase 3
Conditions Chronic Lymphocytic Leukemia
Delaware Valley sites
- TG Therapeutics Investigational Trial Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory